Recently, increasing attention has been given to a subset of mature B-cell lymphomas with both MYC and BCL2 rearrangements, which have been defined as “double hit” lymphomas (DH lymphomas) because of their aggressive clinical course and resistance to conventional chemotherapy [1]. Here, MYC is linked to B-cell non-Hodgkin lymphoma.